安裝中文字典英文字典辭典工具!
安裝中文字典英文字典辭典工具!
|
- IMFINZI® (durvalumab) | Immunotherapy for Certain Cancers
IMFINZI® (durvalumab) is an immunotherapy approved to treat patients with NSCLC, SCLC, bile duct cancer, unresectable hepatocellular carcinoma, muscle-invasive bladder cancer, and advanced or recurrent endometrial cancer
- Stage 3 Non-Small Cell Lung Cancer Immunotherapy - IMFINZI
IMFINZI is a medicine that may treat certain cancers by working with your immune system IMFINZI can cause your immune system to attack normal organs and tissues in any area of your body and can affect the way they work
- How IMFINZI® (durvalumab) Works Against NSCLC
IMFINZI is a prescription medicine used to treat adults with a type of lung cancer called non-small cell lung cancer (NSCLC) IMFINZI may be used when your NSCLC has not spread outside your chest, cannot be removed by surgery, and has responded or stabilized with initial treatment with chemotherapy that contains platinum, given at the same time
- What is IMFINZI® (durvalumab) – Treatment for ES-SCLC
IMFINZI® (durvalumab) is an FDA-approved immunotherapy treatment for adults with extensive-stage small cell lung cancer (ES-SCLC) in combination with chemotherapy
- Non-Small Cell Lung Cancer (NSCLC) Treatment Options – IMFINZI . . .
Learn more about non-small cell lung cancer (NSCLC) treatment options with IMFINZI® (durvalumab), an FDA approved immunotherapy that could be a part of your treatment plan
- Frequently Asked Questions | IMFINZI® (durvalumab)
Find answers to your questions about IMFINZI, an immunotherapy for Unresectable Stage 3 Non-Small Cell Lung Cancer (NSCLC) For Patients Caregivers For Healthcare Professionals »
- What is IMFINZI® (durvalumab) | Approved Treatment for Stage 3 NSCLC
IMFINZI is a prescription medicine used to treat adults with a type of lung cancer called non-small cell lung cancer (NSCLC) IMFINZI may be used when your NSCLC has not spread outside your chest, cannot be removed by surgery, and has responded or stabilized with initial treatment with chemotherapy that contains platinum, given at the same time
- What Is IMFINZI® (durvalumab)?
IMFINZI ® (durvalumab) is a prescription medicine used to treat a type of lung cancer called non-small cell lung cancer (NSCLC) IMFINZI may be used when your NSCLC has not spread outside your chest, cannot be removed by surgery, and has responded or stabilized with initial treatment with chemotherapy that contains platinum, given at the same
|
|
|